“…If it will be possible to predict ENE before surgery, even NCR could be adapted to this patient group. For example, for bladder cancer Smith and colleagues have developed a 20-gene panel able to stratify patients into low or high risk of nodal metastases (19,20). Notably, a recent work has suggested the molecular marker PIM-1 is a significant predictor for nodal metastasis in EC (21).…”